SCHEMBL31663520

SCHEMBL31663520

Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2cc(C#N)c(-c3ccccc3)c(-c3ccccc3)c2-c2ccc(-n3c4ccccc4c4cc(C)ccc43)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.38
PDE1C Q14123 1/20 0.38
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 6/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36
HPGD P15428 6/20 0.35
GAA P10253 2/20 0.35
GALR3 O60755 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663564 0.91 PDE9A (0.38) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663625 0.90 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31273187 0.89 KDM4E (0.38) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663610 0.88 CYP1A2 (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663632 0.87 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663554 0.87 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31272959 0.86 TGFBR1 (0.39) PDE9APDE1CALDH1A1KDM4ECYP1A2
SCHEMBL31273030 0.85 PDE9A (0.39) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31272663 0.85 PDE9A (0.39) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663574 0.85 KDM4E (0.45) PDE9APDE1CALDH1A1KDM4ERXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 PDE9A 4069/4885PDE1C 4875/4885ALDH1A1 242/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 PDE9A 4069/4885PDE1C 4875/4885ALDH1A1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.